Clinical Trial Update: Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a curcumin-piperine formulation to reduce ureteral stent-related inflammation and symptoms in patients with cancer. The study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Curcumin (curcumin)
• Piperine (Piperine)

Snippet

Sponsor: Mayo Clinic | Conditions: Bladder Spasm, Malignant Neoplasm | Phase 1 | Status: COMPLETED